IB Acquisition Corp. Common Stock

NASDAQ:IBAC USA Shell Companies
Market Cap
$61.42 Million
Market Cap Rank
#21598 Global
#7721 in USA
Share Price
$10.70
Change (1 day)
-0.37%
52-Week Range
$10.28 - $10.74
All Time High
$10.74
About

IB Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in North America, Europe, and Asia. IB Acquisition Corp. was incorporated in 2020 and is based in Boca Raton, Florida.

IB Acquisition Corp. Common Stock (IBAC) - Net Assets

Latest net assets as of December 2025: $15.24 Million USD

Based on the latest financial reports, IB Acquisition Corp. Common Stock (IBAC) has net assets worth $15.24 Million USD as of December 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($16.41 Million) and total liabilities ($1.16 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $15.24 Million
% of Total Assets 92.92%
Annual Growth Rate 2112.43%
5-Year Change N/A
10-Year Change N/A
Growth Volatility 199.12

IB Acquisition Corp. Common Stock - Net Assets Trend (2022–2025)

This chart illustrates how IB Acquisition Corp. Common Stock's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for IB Acquisition Corp. Common Stock (2022–2025)

The table below shows the annual net assets of IB Acquisition Corp. Common Stock from 2022 to 2025.

Year Net Assets Change
2025-09-30 $15.30 Million -87.15%
2024-09-30 $119.08 Million +2191453.66%
2023-09-30 $-5.43K -485.39%
2022-09-30 $1.41K --

Equity Component Analysis

This analysis shows how different components contribute to IB Acquisition Corp. Common Stock's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 68015800.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (September 2025)

Component Amount Percentage
Common Stock $15.98 Million 104.45%
Other Components $425.00 0.00%
Total Equity $15.30 Million 100.00%

IB Acquisition Corp. Common Stock Competitors by Market Cap

The table below lists competitors of IB Acquisition Corp. Common Stock ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in IB Acquisition Corp. Common Stock's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 119,078,158 to 15,301,992, a change of -103,776,166 (-87.1%).
  • Net income of 3,416,169 contributed positively to equity growth.
  • Dividend payments of 5,130,712 reduced retained earnings.
  • Share repurchases of 106,131,025 reduced equity.
  • Other factors increased equity by 4,069,402.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income $3.42 Million +22.32%
Dividends Paid $5.13 Million -33.53%
Share Repurchases $106.13 Million -693.58%
Other Changes $4.07 Million +26.59%
Total Change $- -87.15%

Book Value vs Market Value Analysis

This analysis compares IB Acquisition Corp. Common Stock's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 7.87x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 119514.37x to 7.87x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2022-09-30 $0.00 $10.70 x
2023-09-30 $0.00 $10.70 x
2024-09-30 $7.56 $10.70 x
2025-09-30 $1.36 $10.70 x

Capital Efficiency Dashboard

This dashboard shows how efficiently IB Acquisition Corp. Common Stock utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 22.32%
  • The company demonstrates strong efficiency in generating profits from shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 0.00%
  • • Asset Turnover: 0.00x
  • • Equity Multiplier: 1.12x
  • Recent ROE (22.32%) is above the historical average (-4.27%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2022 -40.99% 0.00% 0.00x 1.96x $-719.00
2023 0.00% 0.00% 0.00x 0.00x $-6.30K
2024 1.57% 0.00% 0.00x 1.01x $-10.04 Million
2025 22.32% 0.00% 0.00x 1.12x $1.89 Million

Industry Comparison

This section compares IB Acquisition Corp. Common Stock's net assets metrics with peer companies in the Shell Companies industry.

Industry Context

  • Industry: Shell Companies
  • Average net assets among peers: $36,677,338
  • Average return on equity (ROE) among peers: -64.57%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
IB Acquisition Corp. Common Stock (IBAC) $15.24 Million -40.99% 0.08x $46.39 Million
Artius II Acquisition Inc. Class A Ordinary Shares (AACB) $-60.27K 0.00% 0.00x $198.37 Million
Artius II Acquisition Inc. Units (AACBU) $-60.27K 0.00% 0.00x $205.28 Million
Ares Acquisition Corporation II (AACT-UN) $931.34 Million 0.00% 0.08x $399.77 Million
AA Mission Acquisition Corp. (AAM-UN) $-559.90 Million 0.00% 0.00x $349.76 Million
Global Acquisitions Corporation (AASP) $3.80 Million -5.26% 0.34x $15.42 Million
ABV Consulting Inc (ABVN) $8.75K -623.31% 2.50x $461.96K
Atlantic Coastal Acquisition Corp II (ACAB) $-8.52 Million 0.00% 0.00x $2.44 Million
Annabidiol Corp (ACBD) $-501.57K 0.00% 0.00x $13.62K
ACRO Biomedical Co Ltd (ACBM) $685.87K -17.12% 0.46x $30.04K
Huaizhong Health Group Inc (ADAD) $-19.47K 0.00% 0.00x $3.15K